WO2024246604 - METHODS FOR MONITORING AN ALLOGENIC TRANSPLANT RECIPIENT FOR POTENTIAL INDICATIONS OF REJECTION
National phase entry is expected:
Publication Number
WO/2024/246604
Publication Date
05.12.2024
International Application No.
PCT/IB2024/000265
International Filing Date
30.05.2024
Title **
[English]
METHODS FOR MONITORING AN ALLOGENIC TRANSPLANT RECIPIENT FOR POTENTIAL INDICATIONS OF REJECTION
[French]
PROCÉDÉS DE SURVEILLANCE D'UN RECEVEUR DE GREFFE ALLOGÉNIQUE POUR DES INDICATIONS POTENTIELLES DE REJET
Applicants **
HOSPITAL FOR HAIR RECONNSTRUCTIVE SURGERY S.R.L.
29b Dumitru Minca Sold. Street
District 4
041406 Bucharest, RO
Inventors
POPESCU, Felix
Salinei Street No. 9
Sector 4
040814 Bucharest, RO
Priority Data
63/504,885
30.05.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1121 | |
| EPO | Filing, Examination | 5011 | |
| Japan | Filing | 593 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2635 |
Total: 9935 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The invention is directed to methods of monitoring potential indications of allogenic organ rejection by monitoring transplanted hair follicles from the same donor of the transplanted organ and administering or modifying immunosuppressive therapy to ameliorate or prevent the onset of acute or chronic organ rejection. Methods of the invention can also be used for selecting a candidate allogeneic solid organ donor for a recipient and for ameliorating the onset of an acute rejection of a transplanted allogeneic solid organ, like a kidney.[French]
.